DNA

7.5358.11%
CO

Christian O. Henry

Independent Chairperson

Mr. Christian O. Henry, MBA, is Independent Director of Ginkgo Bioworks Holdings, Inc. from 2016. He served as Independent Director at CM Life Sciences III Inc. since April 07, 2021 until December 2021. He had been President and Chief Executive Officer at Pacific Biosciences of California, Inc. September 14, 2020 until August 05, 2026 and its Director since July 27, 2018 and serves as its Senior Business Advisor since August 05, 2026 and served as its Interim Chief Financial Officer since December 06, 2024 until March 31, 2025. Mr. Henry served as Independent Chairman of the Board at Pacific Biosciences of California, Inc. since August 2018 until September 2020. Mr. Henry serves as Independent Chairman at Wave Life Sciences, Inc. since October 16, 2017. He has been Independent Director of WAVE Life Sciences Ltd since November 10, 2016. Mr. Henry served as the Chief Commercial Officer of Illumina, Inc. from 2015 to January 31, 2017 and as its Executive Vice President for Commercial Operations from December 1, 2015 to January 31, 2017. Mr. Henry served as Senior Vice President of Illumina Inc. since 2006 until 2009 and again since 2010 until December 7, 2015 and served as its General Manager of Genomic Solutions from 2012 to 2014. He served as Chief Financial Officer of Illumina Inc. from June 6, 2005 to 2012 and served as its Principal Accounting Officer. He served as Senior Vice President of Corporate Development & Chief Financial Officer at Illumina Inc. since August 2009 until 2010. Mr. Henry has leadership experience, including in executive-level positions at Illumina, where he has been a key member of the team that has driven the company?s strategy, which has led to significant revenue growth for the organization. During his tenure at Illumina, Mr. Henry has served in multiple roles, including Chief Financial Officer, General Manager of Life Sciences from 2010 to 2012. Mr. Henry served as Acting General Manager of Sequencing Division of Illumina Inc. since February 1, 2008 and also served as its Vice President since June 6, 2005 until 2006. Prior to joining Illumina in 2005, Mr. Henry served as Chief Financial Officer of Tickets.com Inc. since September 2003 to 2005. Prior to that, he served as Vice President of Finance and Corporate Controller of Affymetrix Inc., from 1999 to 2003, where he oversaw accounting, planning, SEC and management reporting, treasury and risk management and later as its Chief Accounting Officer from 1997 to 1999. He was employed at Nektar Therapeutics and Ernst & Young LLP. In 1997, Mr. Henry joined Nektar Therapeutics (formerly Inhale Therapeutic Systems, Inc.), as Corporate Controller and later as its Chief Accounting Officer from 1997 to 1999. Since 1996, Mr. Henry served as General Accounting Manager of Sugen, Inc. Mr. Henry began his career in 1992 at Ernst & Young LLP, where he was a Senior Accountant through 1996. He is a Certified Public Accountant. He was a Director of CM Life Sciences Holdings III LLC from April 2021 to December 2021. Mr. Henry received BA in Biochemistry and Cell Biology from the University of California, San Diego and an MBA with a concentration in finance from the University of California, Irvine.

Positions